Our Blog | Biosimilars & Generics | AAM

Trade Agreement: 3 Obstacles to More Affordable Medicines in the U.S.

Apr 1, 2019 | Jonathan Kimball

NAFTA 2.0: 3 Obstacles to More Affordable Medicines in the U.S.

Mar 28, 2019 | Erica Klinger

AAM Wins Bronze Award from Association TRENDS

Healthcare Leadership Luncheon sponsored by Mylan N.V. and powered by Women in Health Policy (WiHP)

Mar 11, 2019 | Anna McDermott-Vitak

Talking Female Leadership at Access! 2019

Feb 26, 2019 | Erica Klinger

Rich’s Generic Story: No Sweat

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Feb 20, 2019 | Craig Burton

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

AAM President and CEO Chip Davis

Feb 15, 2019 | Rachel Schwartz

Access! New Orleans Style: An Industry Steps Up

Alex Azar - HHS Secretary Live from Access! 2019

Feb 6, 2019 | Allen Goldberg

Alex Azar to Speak at Access! 2019

Generic Savings by State

Jan 30, 2019 | Brett Michelin

From Sea to Shining Sea: Generic Savings State by State

Jonnie's Story

Jan 16, 2019 | Rachel Schwartz

Thanks to Her Generic Prescriptions, Jonnie is Oklahoma O.K.

Take Our Generic Prescriptions Quiz!

Jan 15, 2019 | Erica Klinger

Take Our Generic Prescriptions Quiz!

AAM's Strategic Priorities for 2019

Nov 28, 2018 | Jewel Smith

You’re Invited! AAM Strategic Priorities Planning for the New Year

BCBS: It’s time to CREATE more choices & lower drug prices

Nov 28, 2018 | Chip Davis

BCBS: It’s time to CREATE more choices & lower drug prices